Literature DB >> 2780127

Dose-response effects of methylphenidate on academic performance and overt behavior in hyperactive children.

R Tannock1, R J Schachar, R P Carr, G D Logan.   

Abstract

In the present study, the effects of 0.3 mg/kg and 1.0 mg/kg of methylphenidate on the overt behavior and academic functioning of 12 children with an established diagnosis of attention deficit disorder with hyperactivity were evaluated. A double-blind, placebo-control, within-subject (crossover) design was used, in which each child was tested four times in each drug condition. Drug conditions were alternated on a bidaily basis and each child received two different drug conditions each day. The academic tasks were designed for evaluation of the relationship between task complexity and dose. Whereas overt behavior improved with increasing dose, academic functioning was improved with methylphenidate, but did not vary with either dose or task complexity. Also, investigated were potential carryover effects of a morning dose of methylphenidate on performance in the afternoon. Behavioral and academic improvements produced by a dose of 0.3 mg/kg in the morning were no longer evident in the afternoon, but a morning dose of 1.0 mg/kg produced behavioral improvements that were clinically and statistically discernible in the afternoon, although the academic improvements had dissipated.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2780127

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  17 in total

Review 1.  Evaluation of Methylphenidate Safety and Maximum-Dose Titration Rationale in Attention-Deficit/Hyperactivity Disorder: A Meta-analysis.

Authors:  Cellina Ching; Guy D Eslick; Alison S Poulton
Journal:  JAMA Pediatr       Date:  2019-07-01       Impact factor: 16.193

Review 2.  Pharmacokinetics and clinical effectiveness of methylphenidate.

Authors:  H C Kimko; J T Cross; D R Abernethy
Journal:  Clin Pharmacokinet       Date:  1999-12       Impact factor: 6.447

3.  Attention-deficit hyperactivity disorder.

Authors:  D C Meek
Journal:  Can Fam Physician       Date:  1990-09       Impact factor: 3.275

4.  Methylphenidate and cognitive flexibility: dissociated dose effects in hyperactive children.

Authors:  R Tannock; R Schachar; G Logan
Journal:  J Abnorm Child Psychol       Date:  1995-04

5.  Efficacy and safety of Ritalin LA, a new, once daily, extended-release dosage form of methylphenidate, in children with attention deficit hyperactivity disorder.

Authors:  Joseph Biederman; Declan Quinn; Margaret Weiss; Sabri Markabi; Meredith Weidenman; Kathryn Edson; Goeril Karlsson; Harald Pohlmann; Sharon Wigal
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

6.  Attention deficits: current concepts, controversies, management, and approaches to classroom instruction.

Authors:  B Busch
Journal:  Ann Dyslexia       Date:  1993-12

Review 7.  Differential cognitive actions of norepinephrine a2 and a1 receptor signaling in the prefrontal cortex.

Authors:  Craig W Berridge; Robert C Spencer
Journal:  Brain Res       Date:  2015-11-22       Impact factor: 3.252

Review 8.  Risks and benefits of drugs used in the management of the hyperactive child.

Authors:  A M Fox; M J Rieder
Journal:  Drug Saf       Date:  1993-07       Impact factor: 5.606

9.  Stimulant treatment in children with attention-deficit/hyperactivity disorder moderates adolescent academic outcome.

Authors:  Robyn L Powers; David J Marks; Carlin J Miller; Jeffrey H Newcorn; Jeffrey M Halperin
Journal:  J Child Adolesc Psychopharmacol       Date:  2008-10       Impact factor: 2.576

Review 10.  Is there an inhibitory-response-control system in the rat? Evidence from anatomical and pharmacological studies of behavioral inhibition.

Authors:  Dawn M Eagle; Christelle Baunez
Journal:  Neurosci Biobehav Rev       Date:  2009-07-15       Impact factor: 8.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.